Top Tweets for #AccessForPatients
Rivaroxaban is a medication used to treat and prevent emboli and blood clots 🩸.
It is on the WHO's List of Essential Medicines 💊.
Following a #shortage in Denmark 🇩🇰 because of market withdrawal by the manufacturer, #parallelimporters could #FillTheGap.
#AccessforPatients
Rivaroxaban is a medication used to treat and prevent emboli and blood clots 🩸.
It is on the WHO's List of Essential Medicines 💊.
Following a #shortage in Denmark 🇩🇰 because of market withdrawal by the manufacturer, #parallelimport could #FillTheGap 💪.
#AccessforPatients
#Medicare’s six protected classes policy is an essential patient safeguard for #immunosuppressed patients. Join us in urging @JoeBiden to block a damaging proposal that would undermine these patient protections: https://t.co/ALiWQ6toGU
@TRIOOkla
#ProtectPartD
#accessforpatients
#Medicare’s six protected classes policy is an essential patient safeguard for people with #epilepsy. Join us in urging @JoeBiden to block a damaging proposal that would undermine these key patient protections: https://t.co/kODTPzn1ZO
#ProtectPartD
#accessforpatients
Marco Greco, President @eupatientsforum comments on the needs and expectations of patients in relation to #pharmacyservices. #COVID19
A main strength of the EU #PharmaStrategy is that it is centred around patients’ needs, with accessibility and affordability of medicines at the core.
Our full position ➡️https://t.co/0n652creht
#AccessforPatients #EUHealthUnion
We encourage everyone to read the full list of recommendations in our recently launched position on the Pricing and Value of Innovative Medicines:
Executive Summary👉 https://t.co/zNCo5sM15L
Position Paper👉 https://t.co/EIn13OXIWt
#AccessForPatients #InnovativeMedicines
We encourage everyone to read the full list of recommendations in our recently launched position on the Pricing and Value of Innovative Medicines:
Executive Summary👉 https://t.co/zNCo5sM15L
Position Paper👉 https://t.co/EIn13OXIWt
#AccessForPatients #InnovativeMedicines
Take a look @eupatientsforum's Executive Summary & Position Paper: The Value and Pricing of #Innovative #Medicines & read the full list of their recommendations:
https://t.co/0VxsrjmLex
https://t.co/bHS2ni9Z3B
#AccessForPatients
We encourage everyone to read the full list of recommendations in our recently launched pricing paper
Executive Summary👉 https://t.co/zNCo5suqed
Position Paper👉 https://t.co/EIn13Pfkl3
#AccessForPatients
A warm thank you to participants and speakers for such a fruitful discussion! We have taken into account all questions and comments, and will follow up, however do not hesitate to contact us if you so wish! We will be continuing this dialogue #AccessForPatients #StrongerTogether
#HTA is vital in the supply chain to deliver innovativion to patients. @EU_Health will have to further push this file. It's getting urgent. Could not agree more @TiemoWolken! @eupatientsforum #AccessForPatients #EUHTA
Agree with @eupatientsforum on differential pricing. Only possible with confidentiality of final net prices.
As always thank you very much Commissioner for your invaluable support! #ForPatientsWithPatients #AccessForPatients 💪
Despite near-universal health coverage, 🇪🇺 patients still have limited access to innovative medicines and treatments. We must do more to address this vital issue. Thank you @eupatientsforum for your position paper & continued support
👉 https://t.co/DgPEZNBFlo
#StrongerTogether
🙏thank you to the panellists at @eupatientsforum launch of the pricing paper for mentioning EU level collaboration on #HTA. This too is a key,not to be neglected dossier, that intersects with other important topics under discussion. #AccessForPatients
Initiatives such as cross border healthcare funding, #patientinvolvement in #HTA & all other processes is necessary & its something some groups in @Europarl_EN have been insisting on. The #TransparencyDirective also needs to be amended (comments from the panel) #AccessForPatients
We are pleased to hear @TomislavSokol mentions the #CohesionFund as an additional source of funding in regards to healthcare and healthcare workforce #AccessForPatients
"EU does not have a health competence because it didn't use to be a priority. Now it is. Joint procurement could also be useful to reduce the price of medicines. There are still many unmet needs but there is so much the EU can do" says @TomislavSokol #AccessForPatients
We encourage everyone to read the full list of recommendations in our recently launched pricing paper
Executive Summary👉 https://t.co/zNCo5suqed
Position Paper👉 https://t.co/EIn13Pfkl3
#AccessForPatients
.@eupatientsforum recommendations from the 'Value and pricing of innovative medicines' paper:
> High-Level strategic dialogue at EU level
> Framework for fair and equtable access
> patient organisations inclusion
> transpacency
More: https://t.co/0YURlzbCM4
#AccessForPatients
"Industry and academic researchers should ensure that meaningful #patientinvolvement is embedded in the R&D process, so that new medicines can demonstrably present added value for patients" #PatientsAsPartners #ForPatientsWithPatients #AccessForPatients @KaisaBxl
What is the #value from the patient perspective?
> Right priorities/needs
> Maximum impact and added value
> benefit for public health
@KaisaBxl @eupatientsforum #AccessForPatients
Most Popular Users
Elon Musk 
@elonmusk
241M followers
Barack Obama
@barackobama
119.2M followers
Cristiano Ronaldo
@cristiano
112.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.1M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.3M followers
KATY PERRY
@katyperry
88.6M followers
Taylor Swift
@taylorswift13
82.5M followers
Lady Gaga
@ladygaga
74M followers
Virat Kohli
@imvkohli
71.3M followers
Kim Kardashian
@kimkardashian
70.2M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.4M followers
Neymar Jr
@neymarjr
64.2M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.7M followers
X
@x
60.8M followers